ConductScience.org, home

Paper2954635

Influence of alpha-interferon therapy on blood lymphoid cells. Studies on antibody production, mixed lymphocyte culture response, mitogen responsiveness and 2'-5'oligoadenylate synthetase activity.

Einhorn S and 4 others. Cancer Immunol Immunother, 1987. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Influence of alpha-interferon therapy on blood lymphoid cells. Studies on antibody production, mixed lymphocyte culture response, mitogen responsiveness and 2'-5'oligoadenylate synthetase activity. Papers, record 2954635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2954635

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Influence of alpha-interferon therapy on blood lymphoid cells. Studies on antibody production, mixed lymphocyte culture response, mitogen responsiveness and 2'-5'oligoadenylate synthetase activity.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.31
iCite
Revised in PubMed
2024-04-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Einhorn SS
2Ling PP
3Einhorn NN
4Strander HH
5Wasserman JJ

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
2',5'-Oligoadenylate SynthetaseMajor topic
Antibody FormationMajor topic
Interferon Type IMajor topic
Adult
Aged
Carcinoma
Condylomata Acuminata
Female
Humans
Lymphocyte Activation
Lymphocyte Culture Test, Mixed
Middle Aged
Ovarian Neoplasms

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16154651Enhancement of the human mixed lymphocyte culture response by pretreating the stimulating cells with interferon.Int Arch Allergy Appl Immunol1980https://conductscience.org/library/papers/6154651PubMed
26166575Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon.Int J Cancer1980https://conductscience.org/library/papers/6166575PubMed
35077733A simple method of freezing and storing live lymphocytes.Tissue Antigens1972https://conductscience.org/library/papers/5077733PubMed
46180109The interferon system in patients with malignant disease.J Interferon Res1982https://conductscience.org/library/papers/6180109PubMed
5282781Interferon and spontaneous cytotoxicity in man. II. Studies in patients receiving exogenous leukocyte interferon.Acta Med Scand1978https://conductscience.org/library/papers/282781PubMed
67119475Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy.J Infect Dis1982https://conductscience.org/library/papers/7119475PubMed
76180085Influence of interferon on poke weed mitogen triggered Ig-secretion by human lymphocytes in vitro.J Interferon Res1981https://conductscience.org/library/papers/6180085PubMed
8294128Effect of prolonged in vivo administration of leukocyte interferon on the mitogen responsiveness of human lymphocytes.Acta Med Scand1979https://conductscience.org/library/papers/294128PubMed
96925979Decrease in the phagocytic activity of peripheral monocytes in patients treated with human interferon-alpha.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6925979PubMed
106180091Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells.J Interferon Res1981https://conductscience.org/library/papers/6180091PubMed
116839546In vitro and in vivo effects of interferon on the response of human lymphocytes to mitogens.Clin Exp Immunol1983https://conductscience.org/library/papers/6839546PubMed
123112404The capacity of blood lymphoid cells to produce alpha- and gamma-interferon is decreased during alpha-interferon therapy.J Clin Lab Immunol1987https://conductscience.org/library/papers/3112404PubMed
136365781Functions of human neutrophilic granulocytes after in vivo exposure to interferon alpha.Infect Immun1984https://conductscience.org/library/papers/6365781PubMed
146182111Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alpha.Int J Cancer1982https://conductscience.org/library/papers/6182111PubMed
155707208Separation of leukocytes from blood and bone marrow. Introduction.Scand J Clin Lab Invest Suppl1968https://conductscience.org/library/papers/5707208PubMed
166559104
Influence of human interferon-alpha therapy on cytotoxic functions of blood lymphocytes. Studies on lectin-dependent cellular cytotoxicity, antibody-dependent cellular cytotoxicity, and natural killer cell activity.
Cancer Immunol Immunother1983https://conductscience.org/library/papers/6559104PubMed
17449915Immune interferon in the circulation of patients with autoimmune disease.N Engl J Med1979https://conductscience.org/library/papers/449915PubMed
184138633Strong stimulation of CBA lymphocytes in the mixed lymphocyte interaction with cells from the H-2-indentical strain C3H.Scand J Immunol1974https://conductscience.org/library/papers/4138633PubMed
196173603Production of interferon in human leukocytes from normal donors with the use of Sendai virus.Methods Enzymol1981https://conductscience.org/library/papers/6173603PubMed
206175461Evaluation of the human interferon system in viral disease.Clin Exp Immunol1981https://conductscience.org/library/papers/6175461PubMed

See all 26 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn Papers
2975951Survival, response and immune effects in a prospectively randomized study of dose strategy for alpha-N1 interferon.Br J Cancer1988https://conductscience.org/library/papers/2975951

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2954635

GET https://conductscience.org/api/papers/v1/2954635/references?page=2